2024-10-28 12:25:53
RhoVac presents 3-year follow-up results of the phase I/II study in prostate cancer
Corporate/ 2023-07-23
RhoVac presents 3-year follow-up results...

STOCKHOLM,Oct. 5,2021-- RhoVac AB ("RhoVac"),a Swedish cancer immunotherapy company,announces today on October 5,2021,that it has ...

Pharmaxis Cleared To Progress To Phase 2 Bone Marrow Cancer Trial
Corporate/ 2023-07-23
Pharmaxis Cleared To Progress To Phase 2...

SYDNEY,Oct. 5,2021-- Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced further positive results of data analy...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release